These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26871947)

  • 41. Amygdalin delays cell cycle progression and blocks growth of prostate cancer cells in vitro.
    Makarević J; Tsaur I; Juengel E; Borgmann H; Nelson K; Thomas C; Bartsch G; Haferkamp A; Blaheta RA
    Life Sci; 2016 Feb; 147():137-42. PubMed ID: 26827990
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation.
    Noble AR; Maitland NJ; Berney DM; Rumsby MG
    Br J Cancer; 2018 Jan; 118(2):189-199. PubMed ID: 29136407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel Imidazopyridine Derivatives Possess Anti-Tumor Effect on Human Castration-Resistant Prostate Cancer Cells.
    Ingersoll MA; Lyons AS; Muniyan S; D'Cunha N; Robinson T; Hoelting K; Dwyer JG; Bu XR; Batra SK; Lin MF
    PLoS One; 2015; 10(6):e0131811. PubMed ID: 26121643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implications.
    Rathkopf DE; Larson SM; Anand A; Morris MJ; Slovin SF; Shaffer DR; Heller G; Carver B; Rosen N; Scher HI
    Cancer; 2015 Nov; 121(21):3853-61. PubMed ID: 26178426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.
    Schmidt A; Meissner RS; Gentile MA; Chisamore MJ; Opas EE; Scafonas A; Cusick TE; Gambone C; Pennypacker B; Hodor P; Perkins JJ; Bai C; Ferraro D; Bettoun DJ; Wilkinson HA; Alves SE; Flores O; Ray WJ
    J Steroid Biochem Mol Biol; 2014 Sep; 143():29-39. PubMed ID: 24565564
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Repurposing of phentolamine as a potential anticancer agent against human castration-resistant prostate cancer: A central role on microtubule stabilization and mitochondrial apoptosis pathway.
    Ho CH; Hsu JL; Liu SP; Hsu LC; Chang WL; Chao CC; Guh JH
    Prostate; 2015 Sep; 75(13):1454-66. PubMed ID: 26180030
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
    Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bicalutamide 150 mg as secondary hormonal therapy for castration-resistant prostate cancer.
    Qian SB; Shen HB; Cao QF; Zhang L; Chen YF; Qi J
    Int Urol Nephrol; 2015 Mar; 47(3):479-84. PubMed ID: 25665794
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model.
    Gleave ME; Sato N; Sadar M; Yago V; Bruchovsky N; Sullivan L
    J Cell Biochem; 1998 Jun; 69(3):271-81. PubMed ID: 9581866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resveratrol inhibits hypoxia-inducible factor-1α-mediated androgen receptor signaling and represses tumor progression in castration-resistant prostate cancer.
    Mitani T; Harada N; Tanimori S; Nakano Y; Inui H; Yamaji R
    J Nutr Sci Vitaminol (Tokyo); 2014; 60(4):276-82. PubMed ID: 25297617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Molecular targeting drug of kinase inhibitors for castration resistant prostate cancer].
    Kosaka T; Oya M
    Nihon Rinsho; 2014 Dec; 72(12):2186-92. PubMed ID: 25518356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP.
    Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M
    Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vitamin K2, a menaquinone present in dairy products targets castration-resistant prostate cancer cell-line by activating apoptosis signaling.
    Dasari S; Samy ALPA; Kajdacsy-Balla A; Bosland MC; Munirathinam G
    Food Chem Toxicol; 2018 May; 115():218-227. PubMed ID: 29432837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blockade of ACK1/TNK2 To Squelch the Survival of Prostate Cancer Stem-like Cells.
    Mahajan NP; Coppola D; Kim J; Lawrence HR; Lawrence NJ; Mahajan K
    Sci Rep; 2018 Jan; 8(1):1954. PubMed ID: 29386546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patterns of stemness-associated markers in the development of castration-resistant prostate cancer.
    Federer-Gsponer JR; Müller DC; Zellweger T; Eggimann M; Marston K; Ruiz C; Seifert HH; Rentsch CA; Bubendorf L; Le Magnen C
    Prostate; 2020 Sep; 80(13):1108-1117. PubMed ID: 32628318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rare histologic transformation of a CTNNB1 (β-catenin) mutated prostate cancer with aggressive clinical course.
    Akhoundova D; Fischer S; Triscott J; Lehner M; Thienger P; Maletti S; Jacquet M; Lubis DSH; Bubendorf L; Jochum W; Rubin MA
    Diagn Pathol; 2024 Jun; 19(1):83. PubMed ID: 38907236
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dual strands of pre-miR‑150 (miR‑150‑5p and miR‑150‑3p) act as antitumor miRNAs targeting SPOCK1 in naïve and castration-resistant prostate cancer.
    Okato A; Arai T; Kojima S; Koshizuka K; Osako Y; Idichi T; Kurozumi A; Goto Y; Kato M; Naya Y; Ichikawa T; Seki N
    Int J Oncol; 2017 Jul; 51(1):245-256. PubMed ID: 28534948
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluating the Therapeutic Effect of Hispidin on Prostate Cancer Cells.
    Chan KC; Basavaraj P; Tsai JC; Viehoever J; Hsieh BY; Li XY; Huang GJ; Huang WC
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063105
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dependence of castration-resistant prostate cancer (CRPC) stem cells on CRPC-associated fibroblasts.
    Adisetiyo H; Liang M; Liao CP; Jeong JH; Cohen MB; Roy-Burman P; Frenkel B
    J Cell Physiol; 2014 Sep; 229(9):1170-6. PubMed ID: 24752784
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antitumor activity of interferon-β1a in hormone refractory prostate cancer with neuroendocrine differentiation.
    Dicitore A; Grassi ES; Borghi MO; Gelmini G; Cantone MC; Gaudenzi G; Persani L; Caraglia M; Vitale G
    J Endocrinol Invest; 2017 Jul; 40(7):761-770. PubMed ID: 28247216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.